Hive gets a buzz from tech deal

Hive gets a buzz from tech deal

24 April 2014 By Reporter

New firm Hive Legal has acted on a capital markets deal for an Australian animal medicine company.

Firms: Hive Legal (Nexvet Biopharma Pty Ltd)

Advertisement
Advertisement

Deal: Nexvet Biopharma Pty Ltd, an Australian veterinary biologic drug developer, is seeking financing from institutional investors for a private placement

Value: $US 31.5 million

SPONSORED CONTENT

Area: Equity Capital Markets

Key Players: The Hive Legal team was led by partner Simon Davidson (pictured). A number of powerful US-based institutional investors will take shares, including Farallon Capital Management and Adage Capital Partners. A range of corporate advisors was also involved, including Cowen and Company and the Blueprint Life Science Group

Deal Significance: The proceeds of the placement will be used for research and development in companion animal health and to assist Nexvet to expand in the US. “Nexvet is a pioneer in animal health and it is great to see Australian companies benefit from the success of recent US IPOs in this space,” said Davidson. Hive Legal was started in February by ex-Minter Ellison partner Mitzi Gilligan and Davidson, who came from DLA Piper.

 

Hive gets a buzz from tech deal
Intro image
lawyersweekly logo
The Women in Law Awards is the benchmark for excellence, recognising the empowering women influencing the Australian legal profession, celebrating the female leaders, role models and future champions of the industry. Register for the waitlist today for the opportunity to attend this remarkable awards ceremony and network with top legal professionals and fellow peers.
Visit womeninlaw.com.au